Infantile haemangioma

C Léauté-Labrèze, JI Harper, PH Hoeger - The Lancet, 2017 - thelancet.com
Summary With a prevalence of 4· 5%, infantile haemangiomas are the most common benign
tumours of infancy, arising in the first few weeks of life and exhibiting a characteristic …

Treatment of infantile haemangiomas: recommendations of a European expert group

PH Hoeger, JI Harper, E Baselga, D Bonnet… - European journal of …, 2015 - Springer
Abstract With a prevalence of 2.6–4.5%, infantile haemangiomas (IH) represent the most
common tumour of infancy. While the majority of IH does not require therapy and regresses …

Incidence and treatment of infantile haemangioma in preterm infants

R Goelz, CF Poets - Archives of Disease in Childhood-Fetal and …, 2015 - fn.bmj.com
Infantile haemangioma (IH) are vascular tumours with a unique growth dynamic, mostly
absent at birth, growth in the first months followed by involution over several years, often …

Consensus statement for the treatment of infantile haemangiomas with propranolol

SL Smithson, M Rademaker, S Adams… - Australasian Journal …, 2017 - Wiley Online Library
Although most infantile haemangiomas do not require treatment due to a natural history of
spontaneous involution, some require early intervention. The Australasian Vascular …

Infantile haemangioma: part II. Risks, complications and treatment

C Léauté‐Labrèze, S Prey… - Journal of the European …, 2011 - Wiley Online Library
Because of their spontaneous involution, most infantile haemangiomas (IH) do not require
therapeutic intervention. However, in 10 to 15% of cases such as segmental and multifocal …

Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines

L Solman, M Glover, PE Beattie… - British Journal of …, 2018 - academic.oup.com
Background Infantile haemangiomas (IH) are the most common vascular tumours of infancy.
Despite their frequency and potential complications, there are currently no unified UK …

Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions

DJJ Hermans, CG Bauland, J Zweegers… - British Journal of …, 2013 - academic.oup.com
Background Infantile haemangioma (IH) is a benign, common and self‐limiting tumour of
infancy; only a minority of cases need active treatment. Currently, propranolol appears …

Low-dose propranolol for infantile haemangioma

ST Tan, T Itinteang, P Leadbitter - Journal of Plastic, Reconstructive & …, 2011 - Elsevier
In 2008, propranolol was serendipitously observed to cause accelerated involution of
infantile haemangioma. However, the mechanism by which it causes this dramatic effect is …

Infantile haemangiomas: a challenge in paediatric dermatology

RA Schwartz, MI Sidor, ML Musumeci… - Journal of the …, 2010 - Wiley Online Library
Infantile haemangiomas, common benign vascular tumours of childhood, are characterized
by rapid growth during the first year of life and a slow regression that is usually completed at …

The prevalence and risk factors of infantile haemangiomas: a case–control study in the Dutch population

MJ Hoornweg, MJC Smeulders… - Paediatric and …, 2012 - Wiley Online Library
Summary Hoornweg MJ, Smeulders MJC, Ubbink DT, van der Horst CMAM. The prevalence
and risk factors of infantile haemangiomas: a case–control study in the Dutch population …